Trial Profile
The Carolina cognition study II: A sub-study of the multicentre, international, randomised, parallel group, double blind study to evaluate caardiovascular safety of linagliptin versus glimpiride in patients with type 2 diabetes mellitus at high cardiovascular risk (the CAROLINA trial)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 16 Jun 2016
Price :
$35
*
At a glance
- Drugs Linagliptin (Primary) ; Glimepiride
- Indications Type 2 diabetes mellitus; Vascular dementia
- Focus Therapeutic Use
- Acronyms Carolina Cognition Sub-study 2
- Sponsors Boehringer Ingelheim
- 12 Jul 2013 New trial record